PCR132 Patients’ Preferences for Newer Second-Line Pharmacological Agents in Type 2 Diabetes
| Autor: | Banjara, B, Poudel, N, Garza, KB, Westrick, SC, Whitley, HP, Ngorsuraches, S |
|---|---|
| Zdroj: | In Value in Health July 2022 25(7) Supplement:S566-S566 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect